독성 및 약물대사 연구를 위한 한국인 부분 간 유래 간세포의 품질 및 활용성 평가

다국어 초록 (Multilingual Abstract)

Demand for in vitro pharmacological evaluation and toxicity test using human hepatocytes has been increasing. In USA and Europe, human hepatocytes obtained from donated whole liver unsuitable for transplantation were distributed to researchers and deposited in cell bank facility as cryopreserved vial. In Korea, however, incidence of transplantation-inappropriate whole liver has been quite low and the whole livers almost have so severe liver disease such as fatty or fibrotic liver that cannot meet the demand. In this study we aimed to isolate human hepatocytes from liver resection surgery-originated partial liver, and assure the isolated human hepatocytes and its cryopreserved hepatocytes to be qualified for the in vitro pharmacological evaluation and drug toxicity tests. We compared those with commercially available human hepatocyte, BD GenTest<SUP>TM</SUP> by cell morphology, hepatic gene expression, urea synthesis, albumin secretion, ammonia removal, and cytochrome P450 induction activities. Changes in hepatotoxic gene expression after cryopreservation are evaluated with a typical hepatotoxic drug, acetaminophen. Consequently, the fresh hepatocytes from the partial liver and its cryopreserved hepatocytes expressed their intrinsic hepatic functions well and showed equal hepatotoxicity gene expression trend regardless to cryopreservation. Therefore, liver resection surgery-originated partial liver can be used as a useful source of human hepatocytes for various pharmacological and hepatotoxicity test.

목차 (Table of Contents)

• Abstract
• 1. 서론
• 2. 재료 및 방법
• 3. 결과 및 고찰
• 4. 결론
• REFERENCES

참고문헌 (Reference)

1 장원희, "세포내형 동결보존액을 이용한 사람 간세포의 동결보존 개선" 한국조직공학과 재생의학회 6 (6): 909-915, 2009

2 Terry, C., "The effects of cryopreservation on human hepatocytes obtained from different sources of liver tissue" 14 : 585-594, 2005

3 Noh, J. K., "Quality and availability evaluation of human hepatocytes isolated from rejected partial livers for toxicology and drug metabolism studies in Korea" 2012

4 Hewitt, N. J., "Primary hepatocytes: Current understanding of the regulation of metabolic enzymes and transporter proteins, and pharmaceutical practice for the use of hepatocytes in metabolism, enzyme induction, transporter, clearance, and hepatotoxicity studies" 39 : 159-234, 2007

5 Ramboer, E., "Primary hepatocyte cultures as prominent in vitro tools to study hepatic drug transporters" 45 : 196-217, 2013

6 Oh, K. T., "Primary culture of human hepatocytes from small size sample" 8 : 285-302, 1992

7 Seglen, P. O., "Preparation of rat liver cells: effect of Ca++ on enzymatic dispersion of isolated, perfused liver" 74 : 450-454, 1972

8 Dunn J. C, "Long-term in vitro function of adult hepatocytes in a collagen sandwich configuration" 7 : 237-245, 1991

9 Gomez-Lechon, M. J., "Human hepatocytes in primary culture: the choice to investigate drug metabolism in man" 5 : 443-462, 2004

10 Richert, L., "Gene expression in human hepatocytes in suspension after isolation is similar to the liver of origin, is not affected by hepatocyte cold storage and cryopreservation, but is strongly changed after hepatocyte plating" 34 : 870-879, 2006

11 Kim, H. M., "Functional human hepatocytes: isolation from small liver biopsy samples and primary cultivation with liver-specific functions" 20 : 565-578, 1995

12 Lee, D. H., "Enhanced liverspecific functions of endothelial cell-covered hepatocyte heterospheroids" 20 : 181-187, 2004

13 Aasa, J., "Effect of solvents on the time-dependent inhibition of CYP3A4 and the biotransformation of AZD3839 in human liver microsomes and hepatocytes" 41 : 159-169, 2013

14 Katenz, E., "Cryopreservation of primary human hepatocytes: the benefit of trehalose as an additional cryoprotective agent" 13 : 38-45, 2007

15 Li, A. P., "Cryopreservation human hepatocytes: Characterization of drug-metabolizing enzyme activities and applications in higher throughput screening assays for hepatotoxicity, metabolic stability, and drug-drug interaction potential" 121 : 17-35, 1999

16 Nishimura, M., "Comparison of inducibility of CYP1A and CYP3A mRNAs by prototypical inducers in primary cultures of human, cynomolgus monkey, and rat hepatocytes" 22 : 178-186, 2007

17 Sakai, Y., "Comparative analysis of gene expression in rat lier tissue and monolayer and spheroid-cultured hepatocytes" 191 : 281-288, 2010

18 신동직, "Association of CYP2C19*2 and *3 Genetic Variants with Essential Hypertension in Koreans" 연세대학교의과대학 53 (53): 1113-1119, 2012

19 Kim, K. A., "Assessment of CYP2C19 genetic polymorphisms in a Korean population using a simultaneous multiplex pyrosequencing method to simultaneously detect the CYP2C19*2, CYP2C19*3, and CYP2C19*17alleles" 35 : 697-703, 2010

20 Ministry of Health and Welfare, "Annual report of the transplant 2012" Korean Network for Organ Sharing 14-15, 2012